A novel HDAC6 inhibitor Tubastatin A: Controls HDAC6-p97/VCP-mediated ubiquitination-autophagy turnover and reverses Temozolomide-induced ER stress-tolerance in GBM cells.

[1]  Xiang Wang,et al.  HPOB, an HDAC6 inhibitor, attenuates corticosterone-induced injury in rat adrenal pheochromocytoma PC12 cells by inhibiting mitochondrial GR translocation and the intrinsic apoptosis pathway , 2016, Neurochemistry International.

[2]  Wei-Ping Li,et al.  Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines , 2016, Neurochemical Research.

[3]  S. Hong,et al.  The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells. , 2015, Cancer letters.

[4]  X. Zhuang,et al.  A PIK3C3–Ankyrin-B–Dynactin pathway promotes axonal growth and multiorganelle transport , 2014, The Journal of cell biology.

[5]  S. Khochbin,et al.  HDAC6–ubiquitin interaction controls the duration of HSF1 activation after heat shock , 2014, Molecular biology of the cell.

[6]  M. Vallejo,et al.  The deadly connection between endoplasmic reticulum, Ca2+, protein synthesis, and the endoplasmic reticulum stress response in malignant glioma cells. , 2014, Neuro-oncology.

[7]  Gira Bhabha,et al.  Activation of cytoplasmic dynein motility by dynactin-cargo adapter complexes , 2014, Science.

[8]  A. W. Almawi,et al.  Aggresome formation is regulated by RanBPM through an interaction with HDAC6 , 2014, Biology Open.

[9]  J. Beijnen,et al.  ABCB1, ABCG2, and PTEN Determine the Response of Glioblastoma to Temozolomide and ABT-888 Therapy , 2014, Clinical Cancer Research.

[10]  P. Gean,et al.  Inhibition of glioma growth by minocycline is mediated through endoplasmic reticulum stress-induced apoptosis and autophagic cell death. , 2013, Neuro-oncology.

[11]  S. Halder,et al.  Role of p97/VCP (Cdc48) in genome stability , 2013, Front. Genet..

[12]  R. Mallik,et al.  Molecular Adaptations Allow Dynein to Generate Large Collective Forces inside Cells , 2013, Cell.

[13]  Frank Jülicher,et al.  Cortical Dynein Controls Microtubule Dynamics to Generate Pulling Forces that Position Microtubule Asters , 2012, Cell.

[14]  J. Weissman,et al.  Road to Ruin: Targeting Proteins for Degradation in the Endoplasmic Reticulum , 2011, Science.

[15]  W. Weiss,et al.  Autophagy and Akt promote survival in glioma , 2011, Autophagy.

[16]  A. Schönthal,et al.  Green tea epigallocatechin gallate enhances therapeutic efficacy of temozolomide in orthotopic mouse glioblastoma models. , 2011, Cancer letters.

[17]  Lunxu Liu,et al.  Akt is the downstream target of GRP78 in mediating cisplatin resistance in ER stress-tolerant human lung cancer cells. , 2011, Lung cancer.

[18]  B. Kraemer,et al.  Proteasome Inhibition Drives HDAC6-Dependent Recruitment of Tau to Aggresomes , 2011, Journal of Molecular Neuroscience.

[19]  Kyle V. Butler,et al.  Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A. , 2010, Journal of the American Chemical Society.

[20]  Devin Dersh,et al.  GRP94 in ER quality control and stress responses. , 2010, Seminars in cell & developmental biology.

[21]  P. Atadja,et al.  Treatment with Panobinostat Induces Glucose-Regulated Protein 78 Acetylation and Endoplasmic Reticulum Stress in Breast Cancer Cells , 2010, Molecular Cancer Therapeutics.

[22]  N. Hirokawa,et al.  Kinesin superfamily motor proteins and intracellular transport , 2009, Nature Reviews Molecular Cell Biology.

[23]  A. Carter,et al.  Dynein Swings into Action , 2009, Cell.

[24]  J. Bradner,et al.  HDAC6 inhibition enhances 17-AAG--mediated abrogation of hsp90 chaperone function in human leukemia cells. , 2008, Blood.

[25]  Thomas C. Chen,et al.  The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas. , 2007, Cancer research.

[26]  T. Yao,et al.  HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates. , 2007, Genes & development.

[27]  C. Boyault,et al.  HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubiquitination , 2007, Oncogene.

[28]  Dan Garza,et al.  HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS , 2007, Nature.

[29]  V. Rybin,et al.  HDAC6–p97/VCP controlled polyubiquitin chain turnover , 2006, The EMBO journal.

[30]  R. Kopito,et al.  HDAC6 and Microtubules Are Required for Autophagic Degradation of Aggregated Huntingtin* , 2005, Journal of Biological Chemistry.

[31]  Maurizio Molinari,et al.  The Use of Calnexin and Calreticulin by Cellular and Viral Glycoproteins* , 2005, Journal of Biological Chemistry.

[32]  S. Jentsch,et al.  A Series of Ubiquitin Binding Factors Connects CDC48/p97 to Substrate Multiubiquitylation and Proteasomal Targeting , 2005, Cell.

[33]  Randal J. Kaufman,et al.  Endoplasmic Reticulum Chaperone Protein GRP78 Protects Cells from Apoptosis Induced by Topoisomerase Inhibitors , 2003, Journal of Biological Chemistry.

[34]  Xiao-Fan Wang,et al.  HDAC6 is a microtubule-associated deacetylase , 2002, Nature.

[35]  L. Stewart,et al.  Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials , 2002, The Lancet.

[36]  S. Schold,et al.  Thresholds of O6-alkylguanine-DNA alkyltransferase which confer significant resistance of human glial tumor xenografts to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or temozolomide. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[37]  Kyle V. Butler,et al.  Rational Design and Simple Chemistry Yield a Superior , Neuroprotective HDAC 6 Inhibitor , Tubastatin A , 2010 .

[38]  J. Bradner,et al.  HDAC 6 inhibition enhances 17-AAG – mediated abrogation of hsp 90 chaperone function in human leukemia cells , 2008 .